Jeffrey Cummings, MD


Jeffrey Cummings, MD

Appointed: 2010

No Patient Satisfaction Reviews
Jeffrey Cummings, MD
Department: Cleveland Clinic Lou Ruvo Center for Brain Health
Location: Lou Ruvo Center for Brain Health
Mail Code Las Vegas
888 W. Bonneville
Las Vegas, NV 89106
Type of Doctor:
Adults Only

Biographical Sketch

Jeffrey L. Cummings, MD, ScD, is Director, Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, Nevada and Cleveland, Ohio.  He is the Camille and Larry Ruvo Chair of the Neurological Institute of Cleveland Clinic and Professor of Medicine (Neurology), Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.  

Dr. Cummings is a world-renowned Alzheimer’s researcher and leader of clinical trials.  He has been recognized for his research and leadership contributions in the field of Alzheimer’s disease through the Henderson Award of the American Geriatrics Society (2006), the Research Award of the John Douglas French Alzheimer’s Research Foundation (2008), and the Ronald and Nancy Reagan Research Award of the national Alzheimer’s Association (2008). In 2010, he was honored by the American Association of Geriatric Psychiatry with their Distinguished Scientist Award.  In 2011, he was awarded a Doctor of Science by his Alma mater, University of Wyoming.  He was featured in the Gentleman’s Quarterly (June 2009) as a “Rockstar of Science.”  

Dr. Cummings is interested in clinical trials, developing new therapies for brain diseases, and the interface of neuroscience and society.

Dr. Cummings completed Neurology residency and a Fellowship in Behavioral Neurology at Boston University, Boston, Massachusetts.  US training was followed by a Research Fellowship in Neuropathology and Neuropsychiatry at the National Hospital for Nervous Diseases, Queen Square, London, England. Dr. Cummings was formerly Professor of Neurology and Psychiatry at UCLA, director of the Mary S. Easton Center for Alzheimer’s Disease Research at UCLA, and director of the Deane F. Johnson Center for Neurotherapeutics at UCLA. He is past president of the Behavioral Neurology Society and of the American Neuropsychiatric Association.  Dr. Cummings has authored or edited 39 books and published over 650 peer-reviewed papers.      

Professional Highlights

President - Behavioral Neurology Section, American Academy of Neurology (1994 - 1996)

Executive Director - American Neuropsychiatric Association (1996)

Education & Fellowships

Doctorate - University of Wyoming
Laramie, WY USA
Fellowship - National Hospital for Nervous Diseases
Neuropathology & Neuropsychiatry
London United Kingdom
Fellowship - Boston University / Boston University Medical Center
Behavioral Neurology
Boston, MA USA
Residency - Boston University / Boston University Medical Center
Boston, MA USA
Internship - Hartford Hospital
Hartford, CT USA
Medical School - University of Washington School of Medicine
Seattle, WA USA
Undergraduate - University of Wyoming
Laramie, WY USA


  • Neurology

Specialty Interests

Alzheimer's disease and Dementia

Awards & Honors

  • Henderson Award of the American Geriatrics Society (2006)
  • Research Award of the John Douglas French Alzheimer’s Research Foundation (2008)
  • Ronald and Nancy Reagan Research Award of the national Alzheimer’s Association (2008)
  • Legacy Award from the Ticki Wilkerson-Kassel Movement Therapy Foundation (2010) 
  • American Association of Geriatric Psychiatry Distinguished Scientist Award (2010)
  • Honorary Doctor of Science by his Alma mater, University of Wyoming (2011)

Innovations & Patents

Neuropsychiatric Inventory (NPI)


Member - American Neurological Association (1992 - present)

Member - American Academy of Neurology (1980 - present)

Member - International Psychogeriatric Association (2000 - present)

Member - American College of Neuropsychopharmacology (2002 - present)

Member - American Society for Experimental Neurotherapeutics (2001 - present)

Treatment & Services

  • Neurology

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 8/18/2014, Dr. Cummings has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Cummings receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Avanir Pharmaceuticals, Inc.
  • Boehringer Ingelheim
  • Genentech, Inc
  • Merck & Co., Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English